EPISODE · Mar 26, 2026 · 2 MIN
Novel Oral Agent Lowers HbA1c, Improves Beta-Cell Function in T2D
from TheBrief.Health · host TheBrief.Health
A novel oral diabetes therapy shows durable HbA1c reduction and beta-cell preservation after short treatment, potentially shifting type 2 diabetes care toward disease-modifying, accessible, and longer-lasting management strategies.
What this episode covers
A novel oral diabetes therapy shows durable HbA1c reduction and beta-cell preservation after short treatment, potentially shifting type 2 diabetes care toward disease-modifying, accessible, and longer-lasting management strategies.
NOW PLAYING
Novel Oral Agent Lowers HbA1c, Improves Beta-Cell Function in T2D
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m